logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12778913 B1

PDFFull Text
Date of Patent:
Nov. 03, 2026

Filed:

Aug. 10, 2023

Treatment of age-related macular degeneration, glaucoma, and diabetic retinopathy with n-acetylcysteine amide (naca) or (2r,2r')-3,3′-disulfanediyl bis(2-acetamidopropanamide)(dinaca)

Applicant:

Nacuity Pharmaceuticals, Inc., Fort Worth, TX (US);

Inventor:

G. Michael Wall, Fort Worth, TX (US);

Assignee:

Nacuity Pharmaceuticals, Inc., Fort Worth, TX (US);

Attorneys:

Edwin S. Flores

Daniel J. Chalker

Chalker Flores, LLP

Primary Examiner:

Paul V Ward

Int. Cl.
CPC ...
A61K 31/16 (2006.01); A61K 31/047 (2006.01); A61K 31/085 (2006.01); A61K 31/194 (2006.01); A61K 31/198 (2006.01); A61K 31/235 (2006.01); A61K 31/355 (2006.01); A61K 31/375 (2006.01); A61K 31/685 (2006.01); A61K 33/42 (2006.01);
U.S. Cl.
CPC ...
A61K 31/16 (2013.01); A61K 31/047 (2013.01); A61K 31/085 (2013.01); A61K 31/194 (2013.01); A61K 31/198 (2013.01); A61K 31/235 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/685 (2013.01); A61K 33/42 (2013.01);
Abstract

The present invention includes a method for the treatment of age-related macular degeneration, glaucoma, or diabetic retinopathy in a human that comprises administering to the human a therapeutically effective amount of N-acetylcysteine amide (NACA) or (2R,2R')-3,3′-disulfanediyl bis(2-acetamidopropanamide) (diNACA) sufficient to treat or reduce the symptoms of the age-related macular degeneration, glaucoma, or diabetic retinopathy.

Find Patent Forward Citations

Quick Actions:

Wall, G.. (2026). Treatment of age-related macular degeneration, glaucoma, and diabetic retinopathy with n-acetylcysteine amide (naca) or (2r,2r')-3,3′-disulfanediyl bis(2-acetamidopropanamide)(dinaca) (U.S. Patent No. 12778913). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12778913

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…